Guojun Geng

Xiamen, 361001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Nanocomposites integrating antigen release and presentation for treatment of sarcoma.

Nanocomposites integrating antigen release and presentation for treatment of sarcoma.

Journal: Colloids and surfaces. B, Biointerfaces

Published: December 04, 2025

Tumor volume change rate based on three-dimensional reconstruction as a predictor of pathological response and survival prognosis in esophageal squamous cell carcinoma with neoadjuvant immunochemotherapy.

Tumor volume change rate based on three-dimensional reconstruction as a predictor of pathological response and survival prognosis in esophageal squamous cell carcinoma with neoadjuvant immunochemotherapy.

Journal: BMC cancer

Published: September 29, 2025

Application of artificial intelligence-assisted education for postoperative pulmonary rehabilitation: a hybrid model of AI and nurse-driven support.

Application of artificial intelligence-assisted education for postoperative pulmonary rehabilitation: a hybrid model of AI and nurse-driven support.

Journal: Journal of cardiothoracic surgery

Published: September 09, 2025

Effects of long-term metformin intake on postoperative clinicopathological characteristics in patients with invasive lung adenocarcinoma and type 2 diabetes mellitus: A retrospective analysis.

Effects of long-term metformin intake on postoperative clinicopathological characteristics in patients with invasive lung adenocarcinoma and type 2 diabetes mellitus: A retrospective analysis.

Journal: PloS one

Published: April 08, 2025

Efficacy and safety of neoadjuvant camrelizumab and apatinib combined with chemotherapy in stage IIIA (N2) NSCLC: a multi-center, single-arm, phase II trial.

Efficacy and safety of neoadjuvant camrelizumab and apatinib combined with chemotherapy in stage IIIA (N2) NSCLC: a multi-center, single-arm, phase II trial.

Journal: BMC medicine

Published: December 31, 2024

Prolonged time interval from neoadjuvant immunotherapy combined with chemotherapy to surgery is related to unimproved pathological response and poor survival prognosis for esophageal squamous cell carcinoma.

Prolonged time interval from neoadjuvant immunotherapy combined with chemotherapy to surgery is related to unimproved pathological response and poor survival prognosis for esophageal squamous cell carcinoma.

Journal: BMC gastroenterology

Published: November 10, 2024

Comparison of efficacy and safety in two versus three cycles of neoadjuvant immunotherapy plus chemotherapy for esophageal squamous cell carcinoma.

Comparison of efficacy and safety in two versus three cycles of neoadjuvant immunotherapy plus chemotherapy for esophageal squamous cell carcinoma.

Journal: Journal of cardiothoracic surgery

Published: September 13, 2024

Metastatic patterns of subcarinal, right and left recurrent laryngeal nerve lymph nodes in thoracic esophageal squamous cell carcinoma without neoadjuvant therapy.

Metastatic patterns of subcarinal, right and left recurrent laryngeal nerve lymph nodes in thoracic esophageal squamous cell carcinoma without neoadjuvant therapy.

Journal: Journal of cancer research and clinical oncology

Published: June 08, 2024

An integrated analysis of the anticarcinogenic role of forkhead box protein 1 in oesophageal squamous cell carcinoma.

An integrated analysis of the anticarcinogenic role of forkhead box protein 1 in oesophageal squamous cell carcinoma.

Journal: Journal of cellular and molecular medicine

Published: December 12, 2023

Onvansertib inhibits the proliferation and improves the cisplatin-resistance of lung adenocarcinoma via β-catenin/c-Myc signaling pathway.

Onvansertib inhibits the proliferation and improves the cisplatin-resistance of lung adenocarcinoma via β-catenin/c-Myc signaling pathway.

Journal: American journal of cancer research

Published: August 03, 2022

International expert consensus on immunotherapy for early-stage non-small cell lung cancer.

International expert consensus on immunotherapy for early-stage non-small cell lung cancer.

Journal: Translational lung cancer research

Published: June 07, 2022

Chinese never smokers with adenocarcinoma of the lung are younger and have fewer lymph node metastases than smokers.

Chinese never smokers with adenocarcinoma of the lung are younger and have fewer lymph node metastases than smokers.

Journal: Respiratory research

Published: May 23, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026